HomeTagsNeuron23

Neuron23

Biotechnology

Neuron23 Expands NEULARK Phase 2 Trial With The Michael J. Fox Foundation Support

News Desk - June 18, 2026

Neuron23® Inc., a clinical-stage biotechnology company on a mission to transform the future of Parkinson’s disease through precision medicine, announced it has received a...

Biotechnology

Neuron23 and QIAGEN Announce Collaboration to Develop the Sequencing Companion Diagnostic for Novel Parkinson’s Disease Drug

PR Newswire - September 15, 2022

Neuron23™ Inc., an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases, and QIAGEN ( NYSE: QGEN;...

Hot Topics

Read Magazine’s Weekly Roundup: Accenture, NASA, UPS, Rocket Lab, Volvo, Microchip Technology, OMNIVISION More!

The Bespoke Space Paradigm: NASA Selects Rocket Lab for Core Sun-Earth Science Missions

Microchip Unveils Radiation-Tolerant, Low-Power, Low-Jitter Six-Output Clock Generator for Simplified Aerospace Timing Systems

Read Magazine’s Weekly Roundup: Accenture, NASA, UPS, Rocket Lab, Volvo, Microchip…

The Bespoke Space Paradigm: NASA Selects Rocket Lab for Core Sun-Earth…

Microchip Unveils Radiation-Tolerant, Low-Power, Low-Jitter Six-Output Clock Generator for Simplified Aerospace…

Sunwoda Energy Unveils Upgraded SunESS H Series to Advance AI-Driven Energy…

Neuron23

Hot Topics

Read Magazine’s Weekly Roundup: Accenture, NASA, UPS, Rocket Lab, Volvo, Microchip Technology, OMNIVISION More!

The Bespoke Space Paradigm: NASA Selects Rocket Lab for Core Sun-Earth Science Missions

Microchip Unveils Radiation-Tolerant, Low-Power, Low-Jitter Six-Output Clock Generator for Simplified Aerospace Timing Systems